1999
DOI: 10.1016/s0165-2478(98)00136-9
|View full text |Cite
|
Sign up to set email alerts
|

Oral vaccination with immune stimulating complexes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
26
0

Year Published

1999
1999
2020
2020

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 49 publications
(28 citation statements)
references
References 23 publications
2
26
0
Order By: Relevance
“…ISCOMs have been reported to induce antibody responses or protective immunity in guinea-pig, turkey, cat, rabbit, dog, seal, sheep, pig, cow, horse or monkeys (Mowat et al, 1999) and induced specific CTL responses (Coulter et al, 1998). Cholera toxin A1 (CTA1-DD) and an unrelated antigen can be incorporated together into the ISCOM, resulting in greatly augmented immunogenicity of the antigen.…”
Section: Immunostimulating Complex (Iscom)mentioning
confidence: 99%
“…ISCOMs have been reported to induce antibody responses or protective immunity in guinea-pig, turkey, cat, rabbit, dog, seal, sheep, pig, cow, horse or monkeys (Mowat et al, 1999) and induced specific CTL responses (Coulter et al, 1998). Cholera toxin A1 (CTA1-DD) and an unrelated antigen can be incorporated together into the ISCOM, resulting in greatly augmented immunogenicity of the antigen.…”
Section: Immunostimulating Complex (Iscom)mentioning
confidence: 99%
“…Easily preparable vaccines such as antigens associated with cellular debris, or currently existing vaccines such as -propiolactoneinactivated viruses should be analysed. In addition, adjuvants that can be delivered orally such as microparticles (Partidos et al, 1999) or ISCOMs (Mowat et al, 1991(Mowat et al, , 1999 should be examined. Microparticles have already been described as oral vaccines in rainbow trout (Lavelle et al, 1997), and ISCOMs have been shown to induce a humoral immune response after oral application in Oreochromis mossambicus (Jenkins et al, 1994).…”
Section: Which Approaches Toward Ctl-stimulating Vaccines Should Bmentioning
confidence: 99%
“…A number of studies have provided evidence for the potential of ISCOMs as particulate adjuvants for both oral (Mowat et al, 1999) and nasal (Hu et al, 2001) vaccines, respectively. Indeed, Aguila et al (2006) demonstrated that diphtheria toxin could be incorporated into ISCOMs, and that this formulation was both effective and well tolerated when administered parenterally and mucosally.…”
Section: Immune Responses Triggered By Iscomsmentioning
confidence: 99%